Stories

Vance's Fraud Task Force Cancels Obamacare Coverage for More Than 760,000 People It Calls "Phantoms" — the Vice President Says "This Is Not About Cutting Off Anybody From Their Benefits," Dr. Oz Says "We're Not Paying Insurance for Nonexistent Ghosts," and Chuck Schumer Says the Administration's Answer to Rising Costs Is to "Kick Hundreds of Thousands More People Off Their Health Insurance"

On September 22, 2026, Vice President JD Vance's White House Task Force to Eliminate Fraud announced that the Centers for Medicare & Medicaid Services was cancelling roughly 315,000 federal-marketplace Affordable Care Act enrollments covering more than 760,000 people, saying they were fraudulent or ineligible and that the move would return about $2.2 billion in taxpayer-funded subsidies. Another 419,000 enrollments were flagged for additional checks on immigration status and income, and CMS froze new agent and broker registrations for six months. Officials pointed to one ring of 40 brokers they said had enrolled 50,000 people. CMS Administrator Dr. Mehmet Oz called the cancelled enrollees "phantoms" and said about 35% of exchange enrollees never used their coverage. Vance insisted the effort was "not about cutting off anybody from their benefits." Health-policy analysts warned that legitimate enrollees who simply missed a notice could lose coverage. The cancellations apply only to the federal HealthCare.gov marketplace, not to states running their own exchanges such as California. Democrats called it retribution disguised as fraud enforcement, six weeks before the midterms and as premiums rise after the expiration of enhanced ACA subsidies.

“We're actually making sure that the people receiving Obamacare subsidies are actually entitled to receive them. Amazingly, we weren't doing that before. … This is not about cutting off anybody from their benefits. It's about cutting off fraudsters from stealing from these programs. … We had a system in this country that rewarded brokers, that made people rich for enrolling fake people in programs that are meant to ensure that our fellow citizens have health care. This was a scandal.”

Twenty-Two States and D.C. Sue to Stop the Rule That Cuts Off Federal Medicaid and CHIP Money for Transgender Minors — Filed Six Weeks Before It Takes Effect, and RFK Jr. Says the Care "Fails to Meet the Evidentiary Standard Our Children Deserve"

On September 2-3, 2026 a coalition of 22 state attorneys general and the District of Columbia, joined by the Governor of Pennsylvania, filed suit in the U.S. District Court for the District of Massachusetts to block a Department of Health and Human Services rule that bars federal Medicaid and CHIP reimbursement for gender-affirming care for minors. The rule, finalized by the Centers for Medicare and Medicaid Services on August 13, 2026 and effective October 13, prohibits federal matching funds for puberty-suppressing medication, hormone therapy and surgery for Medicaid beneficiaries under 18 and CHIP beneficiaries under 19 — while leaving the identical treatments reimbursable when provided to patients who are not transgender. Children already on hormone therapy get up to six months of continued funding after the effective date. HHS received more than 30,000 comments on the proposal; more than 90 percent opposed it. The complaint argues the rule exceeds HHS's statutory authority, misuses the evidence offered to justify it, and would set a precedent that the executive branch can substitute a categorical agency ban for the individualized judgments of licensed clinicians without any authorization from Congress. Oregon Attorney General Dan Rayfield led the filing; California's Rob Bonta, Illinois's Kwame Raoul, Maryland's Anthony Brown, Connecticut's William Tong and Massachusetts's Andrea Joy Campbell co-led. HHS Secretary Robert F. Kennedy Jr. had defended the rule when it was finalized in August, saying the government would no longer fund procedures he characterized as carrying risk of irreversible harm.

“His actions are cruel and illegal, and we have sued and already secured multiple federal court orders to stop him. We will vigorously prosecute our litigation to ensure Connecticut families and providers may continue to live their lives and do their jobs free from cruel partisan meddling.”

Trump Adds Nine More Drugmakers to His Most-Favored-Nation Pricing Deals and Asks Congress to Write Them Into Law — and His Health Secretary Says the President Called Him and Dr. Oz "Every Hour of the Day" and Made Clear Their Jobs Depended on It

On Monday, August 31, 2026, President Trump announced from the White House that nine more pharmaceutical manufacturers — Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals and UCB — had agreed to "most-favored-nation" pricing, under which state Medicaid programs pay the lowest price the manufacturer charges in a comparable wealthy country. That brings the running total to 26 companies, which the White House says covers roughly 89 to 90 percent of the branded drug market, and which the administration projects will save Americans more than $600 billion over a decade. The announcement was staged nine weeks before the midterms, into an affordability argument Democrats have been running against Republicans all year. Trump used it to press Congress: he said the company-by-company deals should be codified in statute so a future president cannot simply let them lapse. The most revealing moment came from inside his own cabinet. Health and Human Services Secretary Robert F. Kennedy Jr., standing beside him, described how the deals got done — Trump calling him and CMS Administrator Mehmet Oz "every hour of the day" and making clear their jobs depended on delivering. Trump's answer, from the same event, was that he had not wanted to follow through: "I didn't want to fire a Kennedy. I wasn't going to do that." Commerce Secretary Howard Lutnick tied the agreements to onshoring pharmaceutical production. The persistent criticism of the program is that the terms are not public. Democrats on the Finance, Ways and Means and Energy and Commerce committees have spent 2026 demanding the texts of the deals — Sen. Ron Wyden and 18 Senate Democrats introduced a Drug Deal Disclosure Act in April — and a Public Citizen analysis found that all 16 companies from the program's earlier rounds raised list prices on 272 products in the first months of 2026. No congressional reaction specific to the August 31 announcement had been recorded as of September 1; the Senate stood adjourned until September 14.

“These agreements are projected to save Americans more than $600 billion over a very short period of time.”

Eleven Weeks Before the Midterms, Hakeem Jeffries Says He Does Not Support Medicare for All or "the DSA Agenda" — and Ro Khanna and Bernie Sanders Push Back the Same Day

On the August 16, 2026 edition of NBC's "Meet the Press," House Democratic Leader Hakeem Jeffries was asked directly whether he supports Medicare for All. He said he does not — "It's not legislation that I currently am co-sponsoring or that I support" — and separately declined to embrace the Democratic Socialists of America's program, saying "I don't support the DSA agenda as has been articulated by the DSA itself." Jeffries framed the party's 2026 message around affordability and a "broad caucus" containing progressives, New Democrats and Blue Dogs. Jeffries had co-sponsored the Medicare for All Act in 2019 and 2021 but did not co-sponsor the 2025 version introduced by Reps. Pramila Jayapal and Debbie Dingell. Rep. Ro Khanna (D-CA), appearing on the same program, took the opposite position, calling Medicare for All "arguably the most important priority" and predicting most House Democrats would back it. Sen. Bernie Sanders (I-VT), the policy's longtime author, weighed in publicly the same weekend, citing polling showing 64 percent support. The exchange put the party's internal fight over health care on national television with 11 weeks until the November midterms, as Democrats eye a House majority in January.

“We are facing the most dangerous, radical, and frankly, Kristen, weird Democrats I’ve seen in my lifetime.”

The Pentagon Publishes the Clinical Rules for Hegseth's Mandatory Testosterone Testing — and Pulls Them Down the Next Day — Seven Weeks After a Senator Who Lost Both Legs in Iraq Said the Program Sounded "Like Gender-Affirming Care to Me"

On September 2, 2026 the Pentagon posted a draft "Clinical Guidance for Health and Human Performance Optimization" implementing Defense Secretary Pete Hegseth's July order that every active-duty and reserve service member aged 30 and older be screened annually for testosterone deficiency, with separate screening pathways written for men and women. On September 3 the document and the accompanying statement from Pentagon spokesman Sean Parnell were removed from the website. A U.S. official said the draft "has been temporarily rescinded to allow for updates," and that interim guidance remains in force — so the mandate itself stands while the clinical rules for carrying it out are rewritten. Hegseth announced the program on July 15, 2026, framing it as restoring rather than enhancing capability and calling it necessary for troops to operate at their "absolute best." Screening is mandatory at 30 and up and voluntary below it, with testosterone replacement therapy available to those who test low. No other military requires the screening absent a specific medical indication, and four of six physicians surveyed by Military Times said there was no solid evidence that universal screening at 30 would improve readiness. The Democratic reaction has run along two lines. Sen. Tammy Duckworth, an Army veteran who lost both legs in Iraq, and Rep. Chrissy Houlahan, an Air Force veteran, both pointed out that a government-funded hormone program for men sits awkwardly beside the same administration's ban on hormone therapy for transgender troops, and both asked why the screening does not extend to women in uniform given elevated infertility rates in the force. Houlahan called it the department's "latest culture-war obsession"; Sen. Mark Kelly, a Navy combat pilot, called the change simply "weird."